PAA 2.78% 17.5¢ pharmaust limited

PharmAust ready to trial monepantel on humans to fight motor neurone disease, page-30

  1. 659 Posts.
    lightbulb Created with Sketch. 1182
    Throughout the interview, it looked to me like Roger was a) pretty tired; and b) being VERY careful about what he said.

    The "other factors...now" comment I believe is vitally important. He's not saying "But we've decided to see if we can rustle up some interest in helping with/shaping the Phase 3." That's in the rear vision mirror now. Nope, this is something tangible that's caused a reconsideration of the trialling strategy that would involve a major player and a licensing agreement - Roger says as much later in the video. And it's happened pretty recently.

    Baby steps, but meaningful steps nonetheless.
    Last edited by Densy: 07/06/22
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
-0.005(2.78%)
Mkt cap ! $68.29M
Open High Low Value Volume
17.5¢ 18.0¢ 16.3¢ $328.1K 1.921M

Buyers (Bids)

No. Vol. Price($)
2 601978 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 80000 2
View Market Depth
Last trade - 11.01am 10/05/2024 (20 minute delay) ?
Last
17.0¢
  Change
-0.005 ( 5.92 %)
Open High Low Volume
17.5¢ 18.0¢ 16.0¢ 2388330
Last updated 11.17am 10/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.